Lawrence, Theodore S.

CD8+ T cells regulate tumour ferroptosis during cancer immunotherapy

Wang, W., Green, M., Choi, J. E., Gijón, M., Kennedy, P. D., Johnson, J. K., Liao, P., Lang, X., Kryczek, I., Sell, A., et al. (2019) · Nature

Ferroptosis and cancer prognosisCancer Immunotherapy and Biomarkers

Cited by 2,880

Tumour-reprogrammed stromal BCAT1 fuels branched-chain ketoacid dependency in stromal-rich PDAC tumours

Zhu, Z., Achreja, A., Meurs, N., Animasahun, O., Owen, S., Mittal, A., Parikh, P., Lo, T.-W., Franco-Barraza, J., Shi, J., et al. (2020) · Nature Metabolism

Pancreatic and Hepatic Oncology ResearchCancer, Hypoxia, and Metabolism

Cited by 204

KRAS Protein Stability Is Regulated through SMURF2: UBCH5 Complex-Mediated β-TrCP1 Degradation

Shukla, S., Allam, U. S., Ahsan, A., Chen, G., Krishnamurthy, P. M., Marsh, K., Rumschlag, M., Shankar, S., Whitehead, C., Schipper, M., et al. (2014) · Neoplasia

Ubiquitin and proteasome pathwaysProtein Kinase Regulation and GTPase Signaling

Cited by 96

Enhancing the Radiation Response in KRAS Mutant Colorectal Cancers Using the c-Met Inhibitor Crizotinib

Cuneo, K. C., Mehta, R. K., Kurapati, H., Thomas, D. G., Lawrence, T. S., & Nyati, M. K. (2019) · Translational Oncology

Colorectal Cancer Treatments and StudiesColorectal Cancer Surgical Treatments

Cited by 38

Inducing Oncoprotein Degradation to Improve Targeted Cancer Therapy

Ray, D., Cuneo, K. C., Rehemtulla, A., Lawrence, T. S., & Nyati, M. K. (2015) · Neoplasia

Protein Degradation and InhibitorsUbiquitin and proteasome pathways

Cited by 22